NSHO-102

N/A

Report date: 2025/02/25 16:56:32
NME

Base Information

Drug NameNSHO-102
Drug Alias NameNSHO-102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-4/beta-7 antagonists
TargetsIntegrin alpha-4/beta-7
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEnsho Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnsho Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A